1.Modified Distal Urethral Polypropylene Sling (Canal Transobturator Tape) Procedure: Efficacy for Persistent Stress Urinary Incontinence After a Conventional Midurethral Sling Procedure.
Chang Hee KIM ; Tae Beom KIM ; Jin Kyu OH ; Sang Jin YOON ; Khae Hawn KIM ; Kwang Taek KIM
International Neurourology Journal 2013;17(1):18-23
PURPOSE: Despite reports of persistent stress urinary incontinence (SUI) in patients after the midurethral sling (MUS) procedure, there is no widely accepted definition or cause of the condition. In many cases, the mesh implanted in the previous MUS procedure has been found to have migrated proximally. The aim of this study was to evaluate the efficacy of the modified distal urethral polypropylene sling, or canal transobturator tape (TOT), procedure for persistent SUI after a conventional MUS procedure on the assumption that persistent SUI after MUS is due to the location of the sling. METHODS: From January 2008 to April 2012, 31 female patients who underwent the canal TOT procedure presented with incontinence or lower urinary tract symptoms (LUTS) were included in this study. We identified patients who had been operated on by use of the conventional MUS procedure at other medical facilities, whose Valsalva leak pressure point was less than 120 cm-H2O by urodynamic study, and who were also diagnosed with persistent SUI. If vaginal or urethral mesh exposure was concomitant with persistent SUI, the mesh was removed completely or in part. Surgical procedures for canal TOT were identical to the original TOT procedures, except in the number and location of the vaginal incisions. Incontinence Impact Questionnaire-Short Form (IIQ-7) and Urogenital Distress Inventory-Short Form (UDI-6) scores were assessed preoperatively and at 3 months postoperatively. RESULTS: There were no intraoperative or postoperative complications. Twenty-eight patients (90.3%) showed improvement in incontinence or other LUTS. Postoperative scores of the IIQ-7 (0.65+/-0.48) and UDI-6 (3.48+/-2.28) were significantly improved compared with preoperative scores (1.26+/-0.58 and 7.52+/-4.30, respectively; P<0.05). CONCLUSIONS: Improper sling location is one of the major causes of persistent SUI after the conventional MUS procedure. Our results demonstrate that canal TOT may be an alternative method in the treatment of persistent SUI after the conventional MUS procedure.
Animals
;
Female
;
Humans
;
Lower Urinary Tract Symptoms
;
Mice
;
Polypropylenes
;
Postoperative Complications
;
Recurrence
;
Suburethral Slings
;
Urinary Incontinence
;
Urodynamics
2.Warm Sitz Bath: Are There Benefits after Transurethral Resection of the Prostate?.
Sang Un PARK ; Seung Hwan LEE ; Yeun Goo CHUNG ; Kyung Kgi PARK ; Sang Yol MAH ; Sung Joon HONG ; Byung Ha CHUNG
Korean Journal of Urology 2010;51(11):763-766
PURPOSE: We aimed to evaluate the efficacy of warm water sitz baths in patients who have undergone transurethral resection of the prostate (TURP) owing to lower urinary tract symptoms secondary to benign prostatic hyperplasia. MATERIALS AND METHODS: We reviewed the records of 1,783 patients who had undergone TURP between 2001 and 2009. In the warm water sitz bath group, patients were instructed to sit in a tub containing lukewarm water at 40-45degrees C for 10 minutes each time. Patients were advised to perform the procedure for at least 5 days immediately after the removal of a Foley urethral catheter. The differences in post-TURP complications between the warm water sitz bath group and the no sitz bath group were compared. RESULTS: After TURP, 359 of the 1,561 patients performed a warm water sitz bath. Complications after TURP, such as hemorrhage, urinary tract infection, urethral stricture, and acute urinary retention were found in 19 (5.3%) and 75 (6.2%) patients in the sitz bath and no sitz bath groups, respectively (p=0.09). There was a significant difference in postoperative complications such as urethral stricture between the warm sitz bath group and the no sitz bath group (p=0.04). The group that did not undergo warm water sitz bath treatment showed a 1.13-fold increased risk of rehospitalization within 1 month after TURP due to postoperative complications compared with the warm water sitz bath group (odds ratio [OR]=1.134; 95% confidence interval [CI], 1.022 to 1.193; p=0.06). CONCLUSIONS: Warm water sitz bath treatment reduced postoperative complications such as urethral stricture. These results suggest that large-scale prospective studies are needed to establish an ideal method and optimal duration of sitz baths.
Baths
;
Hemorrhage
;
Humans
;
Hydrotherapy
;
Lower Urinary Tract Symptoms
;
Postoperative Complications
;
Prostate
;
Prostatic Hyperplasia
;
Transurethral Resection of Prostate
;
Urethral Stricture
;
Urinary Catheters
;
Urinary Retention
;
Urinary Tract Infections
;
Water
3.LUTS in BPH patients with histological prostatitis before and after transurethral resection of the prostate.
Xiang-Hua HUANG ; Bin QIN ; Yi-Wen LIANG ; Qing-Guo WU ; Chang-Zan LI ; Gang-Shan WEI ; Han-Chu JI ; Yang-Bing LIANG ; Hong-Qiu CHEN ; Ting GUAN
National Journal of Andrology 2013;19(1):35-39
OBJECTIVETo investigate the effects of transurethral resection of the prostate (TURP) on lower urinary tract symptoms (LUTS) in patients with benign prostatic hyperplasia (BPH) complicated by histological prostatitis.
METHODSThis study included 432 cases of BPH pathologically confirmed after TURP. Excluding those with LUTS-related factors before and after surgery and based on the international prostatitis histological classification of diagnostic criteria, the remaining 144 cases were divided into groups A (pure BPH, n = 30), B (mild inflammation, n = 55), C (moderate inflammation, n = 31), and D (severe inflammation, n = 28). Each group was evaluated for LUTS by IPSS before and a month after surgery.
RESULTSA total of 399 cases (92.4%) were diagnosed as BPH with histological prostatitis, 269 (67.4%) mild, 86 (21.6%) moderate and 44 (11.0%) severe. The preoperative IPSS was 21.43 +/- 6.09 in group A, 21.75 +/- 5.97 in B, 27.84 +/- 4.18 in C and 31.00 +/- 2.92 in D, with statistically significant differences among different groups (P < 0.001) except between A and B (P = 1.000); the postoperative IPSS was 5.60 +/- 2.16 in A, 7.36 +/- 2.77 in B, 11.55 +/- 3.39 in C and 16.89 +/- 3.37 in D, with statistically significant differences among different groups (P < 0.01), and remarkably lower than the preoperative one (P < 0.001). Almost all the infiltrating inflammatory cells in BPH with histological prostatitis were lymphocytes.
CONCLUSIONBPH is mostly complicated with histological chronic prostatitis. The severity of LUTS is higher in BPH patients with histological prostatitis than in those without before and after TURP, and positively correlated with the grade of inflammation. Those complicated with moderate or severe histological prostatitis should take medication for the management of LUTS.
Chronic Disease ; Humans ; Lower Urinary Tract Symptoms ; Male ; Prostatic Hyperplasia ; complications ; surgery ; Prostatitis ; complications ; surgery ; Transurethral Resection of Prostate ; Treatment Outcome
4.Phosphodiesterase type 5 inhibitors for lower urinary tract symptoms induced by benign prostatic hyperplasia: an update.
Peng-Bin HE ; Pei-Jin ZHA ; Dong-Ping XU
National Journal of Andrology 2014;20(7):651-656
Medication has become the first-line option for the management of lower urinary tract symptoms induced by benign prostatic hyperplasia (LUTS/BPH) for its advantages in controlling the symptoms, inhibiting BPH progression, and reducing serious complications and surgical risks. Recent years have witnessed remarkable achievement in the studies of phosphodiesterase type 5 inhibitors (PDE5-Is) in the treatment of LUTS/BPH. PDE5-Is can effectively alleviate LUTS/BPH, with even better efficacy when combined with al-ARAs.
Humans
;
Lower Urinary Tract Symptoms
;
drug therapy
;
etiology
;
Male
;
Phosphodiesterase 5 Inhibitors
;
therapeutic use
;
Prostatic Hyperplasia
;
complications
5.Clinical significance of distally located periurethral calcification in patients with lower urinary tract symptoms of benign prostate hyperplasia.
Seong Hyeon YU ; Do Gyeong LIM ; Sun-Ouck KIM
Asian Journal of Andrology 2023;25(3):361-365
This study evaluated the association of periurethral calcification (PUC) with uroflowmetric parameters and symptom severity in male patients with lower urinary tract symptoms (LUTS) of benign prostatic hyperplasia (BPH). The data were collected from a prospectively maintained database of 1321 men with LUTS of BPH who visited Chonnam National University Hospital (Gwang-ju, Korea) from January 2015 to December 2019. PUC severity and location were evaluated on the midsagittal plane during transrectal ultrasonography. Relationships among age, prostate-related parameters, International Prostate Symptom Score (IPSS), and uroflowmetric parameters were assessed. Among the 1321 patients in this study, 530 (40.1%) had PUC. Patients with PUC had significantly higher IPSS (mean ± standard deviation [s.d.]: 15.1 ± 8.7 vs 13.1 ± 7.9; P < 0.001) and lower peak flow rate (Qmax; mean ± s.d.: 12.4 ± 6.6 ml s-1 vs 14.7 ± 13.3 ml s-1; P < 0.001), compared with patients who did not have PUC. Analyses according to PUC severity revealed that patients with severe PUC had higher prostate-specific antigen (PSA) level (P = 0.009), higher total IPSS (P < 0.001), lower Qmax (P = 0.002), and smaller prostate volume (P < 0.001), compared with patients who had non-severe (mild or moderate) PUC. Multivariate analysis showed that distal PUC was independently associated with high total IPSS (P = 0.02), voiding symptom score (P = 0.04), and storage symptom score (P = 0.023), and low Qmax (P = 0.015). In conclusion, PUC was significantly associated with worse LUTS parameters in terms of IPSS and Qmax. Furthermore, distally located PUC was independently associated with worse LUTS of BPH in men.
Humans
;
Male
;
Prostatic Hyperplasia/diagnostic imaging*
;
Prostate/diagnostic imaging*
;
Clinical Relevance
;
Hyperplasia
;
Lower Urinary Tract Symptoms/complications*
;
Calcinosis/diagnostic imaging*
6.Tadalafil for lower urinary tract symptoms secondary to benign prostatic hyperplasia.
National Journal of Andrology 2012;18(12):1147-1151
Tadalafil, as a selective phosphodiesterase type 5 inhibitor (PDE5I), has revolutionized the treatment of erectile dysfunction (ED) in men. Conventional management of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH), which is highly complex and likely multifactorial, is associated with unwanted side effects. Innovative once-daily tadalafil regimen is effective in treating the signs and symptoms of BPH. In recent trials in men with BPH, tadalafil significantly improved total IPSS over the initial 12 weeks of medication. Moreover, tadalafil is effective in treating both ED and the signs and symptoms of BPH. In this study, we review the current state of this new management strategy for LUTS secondary to BPH, highlighting the published reports on the efficacy and tolerability of tadalafil.
Carbolines
;
therapeutic use
;
Humans
;
Lower Urinary Tract Symptoms
;
drug therapy
;
etiology
;
Male
;
Prostatic Hyperplasia
;
complications
;
drug therapy
;
Retrospective Studies
;
Tadalafil
;
Treatment Outcome
7.Minimally invasive techniques in the treatment of benign prostatic hyperplasia: An update.
National Journal of Andrology 2016;22(5):387-392
Lower urinary tract symptoms (LUTS) resulting from benign prostatic hyperplasia (BPH) obviously impair the quality of life of middle-aged and elderly men. Current management of BPH includes wait-and-watch, medical therapy, and conventional surgery. As a new approach, minimally invasive surgery has been playing an increasingly important role in the management of BPH, with potential advantages of less operative trauma, quicker recovery, lower risk of postoperative complications and higher quality of life. This review mainly discusses prostatic urethral lift (Urolift® System), transurethral water vapor therapy (Rezūm® System) and robot-guided high-energy water ablation (PROCEPT Aquablation™ System).
Aged
;
Humans
;
Lower Urinary Tract Symptoms
;
Male
;
Middle Aged
;
Minimally Invasive Surgical Procedures
;
Postoperative Complications
;
Prostatic Hyperplasia
;
surgery
;
Quality of Life
;
Treatment Outcome
;
Urethra
;
surgery
8.Transurethral Procedures for Lower Urinary Tract Symptoms Resulting From Benign Prostatic Enlargement: A Quality and Meta-Analysis.
Seung Wook LEE ; Jong Bo CHOI ; Kyu Sung LEE ; Tae Hyoung KIM ; Hwancheol SON ; Tae Young JUNG ; Seung June OH ; Hee Jong JEONG ; Jae Hyun BAE ; Young Suk LEE ; Joon Chul KIM
International Neurourology Journal 2013;17(2):59-66
PURPOSE: Thanks to advancements in surgical techniques and instruments, many surgical modalities have been developed to replace transurethral resection of the prostate (TURP). However, TURP remains the gold standard for the surgical treatment of benign prostatic hyperplasia (BPH). We conducted a meta-analysis on the efficacy and safety of minimally invasive surgical therapies for BPH compared with TURP. METHODS: This meta-analysis used a Medline search assessing the period from 1997 to 2011. A total of 784 randomized controlled trials were identified in an electronic search. Among the 784 articles, 36 randomized controlled trials that provided the highest level of evidence (level 1b) were included in the meta-analysis. We also conducted a quality analysis of selected articles. RESULTS: Only 2 articles (5.56%) were assessed as having a low risk of bias by use of the Cochrane collaboration risk of bias tool. On the other hand, by use of the Jadad scale, there were 26 high-quality articles (72.22%). Furthermore, 28 articles (77.78%) were assessed as high-quality articles by use of the van Tulder scale. Holmium laser enucleation of the prostate (HoLEP) showed the highest reduction of the International Prostate Symptom Score compared with TURP (P<0.0001). Bipolar TURP, bipolar transurethral vaporization of the prostate, HoLEP, and open prostatectomy showed superior outcome in postvoid residual urine volume and maximum flow rate. The intraoperative complications of the minimally invasive surgeries had no statistically significant inferior outcomes compared with TURP. Also, there were no statistically significant differences in any of the modalities compared with TURP. CONCLUSIONS: The selection of an appropriate surgical modality for BPH should be assessed by fully understanding each patient's clinical conditions.
Bias (Epidemiology)
;
Cooperative Behavior
;
Electronics
;
Electrons
;
Hand
;
Holmium
;
Intraoperative Complications
;
Lasers, Solid-State
;
Lower Urinary Tract Symptoms
;
Phosphates
;
Prostate
;
Prostatectomy
;
Prostatic Hyperplasia
;
Titanium
;
Transurethral Resection of Prostate
;
Volatilization
9.Six novel minimally invasive therapies for benign prostatic hyperplasia.
Journal of Zhejiang University. Medical sciences 2023;52(2):162-168
Benign prostatic hyperplasia (BPH) is the most common cause of lower urinary tract symptoms in men. When drug treatment is ineffective or conventional surgery is not suitable, novel minimally invasive therapies can be considered. These include prostatic urethral lift, prostatic artery embolisation, water vapor thermal therapy, Aquablation-image guided robotic waterjet ablation, temporary implantable nitinol device and prostatic stents. These novel therapies can be performed in outpatient setting under local anesthesia, with shorter operative and recovery times, and better protection of ejaculatory function and erectile function. General conditions of the patient and advantages and disadvantages of the each of these therapies should be fully considered to make individualized plans.
Male
;
Humans
;
Prostatic Hyperplasia/complications*
;
Stents/adverse effects*
;
Embolization, Therapeutic/adverse effects*
;
Lower Urinary Tract Symptoms/surgery*
;
Treatment Outcome
;
Minimally Invasive Surgical Procedures
10.The clinical presentation and diagnosis of ketamine-associated urinary tract dysfunction in Singapore.
Jacklyn YEK ; Palaniappan SUNDARAM ; Hakan AYDIN ; Tricia KUO ; Lay Guat NG
Singapore medical journal 2015;56(12):660-quiz 665
Ketamine is a short-acting anaesthetic agent that has gained popularity as a 'club drug' due to its hallucinogenic effects. Substance abuse should be considered in young adult patients who present with severe debilitating symptoms such as lower urinary tract symptoms, even though the use of controlled substances is rare in Singapore. Although the natural history of disease varies from person to person, a relationship between symptom severity and frequency/dosage of abuse has been established. It is important to be aware of this condition and have a high degree of clinical suspicion to enable early diagnosis and immediate initiation of multidisciplinary and holistic treatment. A delayed diagnosis can lead to irreversible pathological changes and increased morbidity among ketamine abusers.
Adult
;
Cystitis
;
drug therapy
;
Cystoscopy
;
Female
;
Fluoroscopy
;
Humans
;
Ketamine
;
adverse effects
;
Lower Urinary Tract Symptoms
;
chemically induced
;
Male
;
Singapore
;
Substance-Related Disorders
;
complications
;
Tomography, X-Ray Computed
;
Ultrasonography
;
Urinary Tract
;
drug effects
;
physiopathology
;
Young Adult